Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review

Jung Han Kim; Hyeong Su Kim; Bum Jun Kim; Hyun Joo Jang; Jin Lee

doi:10.18632/oncotarget.20087

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review

Jung Han Kim _, Hyeong Su Kim, Bum Jun Kim, Hyun Joo Jang and Jin Lee

PDF | HTML | How to cite

Oncotarget. 2017; 8:90351-90357. https://doi.org/10.18632/oncotarget.20087

Metrics: PDF 1418 views | HTML 2439 views | ?

Abstract

Jung Han Kim1, Hyeong Su Kim1, Bum Jun Kim1,3, Hyun Joo Jang2 and Jin Lee2

1Division of Hemato-Oncology, Department of Internal Medicine, Kangnam Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Seoul 07441, Republic of Korea

2Division of Gastroenterology, Department of Internal Medicine, Dongtan Sacred-Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, Hwasung 18450, Republic of Korea

3Department of Internal Medicine, National Army Capital Hospital, The Armed Forces Medical Command, Sungnam 13574, Republic of Korea

Correspondence to:

Jung Han Kim, email: [email protected]

Hyun Joo Jang, email: [email protected]

Keywords: c-Met, hepatocellular carcinoma, prognostic value, meta-analysis

Received: June 08, 2017 Accepted: July 26, 2017 Published: August 09, 2017

ABSTRACT

The overexpression of c-Met protein has been detected in hepatocellular carcinoma (HCC). However, its prognostic impact remains uncertain. We performed this meta-analysis to evaluate the prognostic value of c-Met overexpression in patients who underwent curative surgical resection for HCC. A systematic computerized search of the electronic databases was carried out. From 5 studies, 1,408 patients who underwent surgical resection for HCC were included in the meta-analysis. Compared with patients with HCC having low c-Met expression, patients with c-Met-high tumor showed significantly worse relapse-free survival (hazard ratio = 1.26 [95% confidence interval, 1.02–1.56], P = 0.03) and overall survival (hazard ratio = 1.16 [95% confidence interval, 1.03–1.31], P = 0.01). In conclusion, our meta-analysis indicates that c-Met overexpression is a significant adverse prognostic factor for recurrence and survival in patients who underwent surgical resection for HCC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20087

Publication Alerts

Meta-Analysis:

Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review

Abstract